William Duke, Jr

2019

In 2019, William Duke, Jr earned a total compensation of $1.7M as Chief Financial Officer principal financial officer at Kaleido Biosciences.

Compensation breakdown

Option Awards$1,675,995
Salary$44,692
Other$277
Total$1,720,964

Duke received $1.7M in option awards, accounting for 97% of the total pay in 2019.

Duke also received $44.7K in salary and $277 in other compensation.

Rankings

In 2019, William Duke, Jr's compensation ranked 6,653rd out of 13,971 executives tracked by ExecPay. In other words, Duke earned more than 52.4% of executives.

ClassificationRankingPercentile
All
6,653
out of 13,971
52nd
Division
Manufacturing
2,530
out of 5,701
56th
Major group
Chemicals And Allied Products
918
out of 2,200
58th
Industry group
Drugs
776
out of 1,886
59th
Industry
Biological Products, Except Diagnostic Substances
186
out of 389
52nd
Source: SEC filing on May 5, 2021.

Duke's colleagues

We found four more compensation records of executives who worked with William Duke, Jr at Kaleido Biosciences in 2019.

2019

Alison Lawton

Kaleido Biosciences

Chief Executive Officer

2019

Jerald Korn

Kaleido Biosciences

General Counsel

2019

Katharine Knobil

Kaleido Biosciences

Chief Medical Officer

2019

Joshua Brumm

Kaleido Biosciences

Chief Financial Officer

News

In-depth

You may also like